InterMune (nasdaq)ITMN Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : InterMune (nasdaq)ITMN

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Secret_Agent_Man who started this subject	9/14/2000 4:33:04 PM
From: IRWIN JAMES FRANKEL	of 508

The Street.com is at it again touting the lockup end for ITMN. thestreet.com "Better yet, there's InterMune Pharmaceuticals (ITMN:Nasdaq - news), which is developing drugs for osteopetrosis and cystic fybrosis, among other ailments. The stock coasted to $47.87 in July, well above its first-day close in the $32 range, and as the chart shows, stubbornly refuses to drop much below $40." I keep getting the feeling that they would like to generate some shorting of ITMN going into the end of the lockup. This is the second article mentioning ITMN which seems odd for a stock that is not on the radar screen. The lockup does end 9/20 for about 8.4 million shares. ij

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next